Cargando…
Inhaled Corticosteroids in Asthma and the Risk of Pneumonia
PURPOSE: Asthma is a common disease that is expensive and burdensome for patients. Inhaled corticosteroids (ICS) are the most important drugs for asthma treatment and are often prescribed long-term. However, the use of ICS has been reported to increase pneumonia, though this remains controversial. W...
Autores principales: | Kim, Min-Hye, Rhee, Chin Kook, Shim, Ji-Su, Park, So Young, Yoo, Kwang Ha, Kim, Bo Yeon, Bae, Hye Won, Sim, Yun Su, Chang, Jung Hyun, Cho, Young-Joo, Lee, Jin Hwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761075/ https://www.ncbi.nlm.nih.gov/pubmed/31552715 http://dx.doi.org/10.4168/aair.2019.11.6.795 |
Ejemplares similares
-
The Impact of Inhaled Corticosteroids on the Prognosis of Chronic Obstructive Pulmonary Disease
por: Park, Ji Won, et al.
Publicado: (2023) -
Prescription Patterns of Oral Corticosteroids for Asthma Treatment and Related Asthma Phenotypes in University Hospitals in Korea
por: Kwon, Jae-Woo, et al.
Publicado: (2022) -
Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD
por: Lee, Eung Gu, et al.
Publicado: (2023) -
Effects of Macrolide and Corticosteroid in Neutrophilic Asthma Mouse Model
por: An, Tai Joon, et al.
Publicado: (2018) -
Heterogeneity of asthma and COPD overlap
por: Kim, Min-Hye, et al.
Publicado: (2018)